AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $552,970 | -21.0% | 7,912 | -18.8% | 0.01% | -20.0% |
| Q2 2023 | $699,916 | +16.9% | 9,740 | +0.4% | 0.02% | +7.1% |
| Q1 2023 | $598,604 | -4.0% | 9,705 | +20.1% | 0.01% | -22.2% |
| Q4 2022 | $623,519 | +47.1% | 8,084 | -15.0% | 0.02% | +12.5% |
| Q3 2022 | $424,000 | +16.8% | 9,511 | +0.3% | 0.02% | 0.0% |
| Q2 2022 | $363,000 | -7.6% | 9,480 | -0.1% | 0.02% | +6.7% |
| Q1 2022 | $393,000 | +4.8% | 9,487 | -5.3% | 0.02% | +15.4% |
| Q4 2021 | $375,000 | +14.0% | 10,017 | -1.2% | 0.01% | 0.0% |
| Q3 2021 | $329,000 | -28.9% | 10,137 | +47.7% | 0.01% | -31.6% |
| Q2 2021 | $463,000 | +33.0% | 6,864 | +11.8% | 0.02% | +18.8% |
| Q1 2021 | $348,000 | -26.7% | 6,141 | -6.6% | 0.02% | -36.0% |
| Q4 2020 | $475,000 | +64.4% | 6,577 | +62.3% | 0.02% | +25.0% |
| Q3 2020 | $289,000 | +7125.0% | 4,053 | +2602.0% | 0.02% | – |
| Q2 2019 | $4,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
| Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
| Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
| RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
| SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
| BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
| Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
| Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
| TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
| Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |